Compounds > tributyrin
Page last updated: 2024-08-17

tributyrin and Malignant Melanoma

tributyrin has been researched along with Malignant Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalho, VFM; Costa-Lotufo, LV; de Lemos, DP; Giacone, DV; Lopes, LB; Maria-Engler, SS; Migotto, A; Zanoni, TB1
Hong, SS; Kang, SN; Lee, MK; Lim, SJ1
Hobbs, ML; Ismail, S; Kurland, JF; Meyn, RE; Munshi, A; Nishikawa, T; Stevens, C; Tanaka, T; Tucker, SL1

Other Studies

3 other study(ies) available for tributyrin and Malignant Melanoma

ArticleYear
Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Nov-15, Volume: 109

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Ceramides; Drug Carriers; Emulsions; Melanoma; Nanoparticles; Paclitaxel; Skin; Skin Absorption; Swine; Triglycerides

2017
Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
    International journal of pharmaceutics, 2012, May-30, Volume: 428, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Carriers; Drug Synergism; Emulsions; HCT116 Cells; Humans; Melanoma; Mice; Oils; Particle Size; Prodrugs; Pyrazoles; Solubility; Sulfonamides; Surface-Active Agents; Triglycerides

2012
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13

    Topics: Acetylation; Antigens, Nuclear; Apoptosis; Blotting, Western; Butyrates; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Ku Autoantigen; Melanoma; Triglycerides

2005